Quest Diagnostics Basic Shares Outstanding 2010-2025 | DGX
Quest Diagnostics annual/quarterly basic shares outstanding history and growth rate from 2010 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
- Quest Diagnostics basic shares outstanding for the quarter ending March 31, 2025 were $111M, a 0% increase year-over-year.
- Quest Diagnostics basic shares outstanding for the twelve months ending March 31, 2025 were $445M, a 0.45% decline year-over-year.
- Quest Diagnostics annual basic shares outstanding for 2024 were $0.111B, a 0.89% decline from 2023.
- Quest Diagnostics annual basic shares outstanding for 2023 were $0.112B, a 3.45% decline from 2022.
- Quest Diagnostics annual basic shares outstanding for 2022 were $0.116B, a 7.2% decline from 2021.
Quest Diagnostics Annual Basic Shares Outstanding
(Millions of US $) |
| 2024 |
$111 |
| 2023 |
$112 |
| 2022 |
$116 |
| 2021 |
$125 |
| 2020 |
$134 |
| 2019 |
$134 |
| 2018 |
$136 |
| 2017 |
$137 |
| 2016 |
$140 |
| 2015 |
$144 |
| 2014 |
$145 |
| 2013 |
$152 |
| 2012 |
$159 |
| 2011 |
$159 |
| 2010 |
$176 |
| 2009 |
$186 |
Quest Diagnostics Quarterly Basic Shares Outstanding
(Millions of US $) |
| 2025-03-31 |
$111 |
| 2024-12-31 |
$111 |
| 2024-09-30 |
$112 |
| 2024-06-30 |
$111 |
| 2024-03-31 |
$111 |
| 2023-12-31 |
$112 |
| 2023-09-30 |
$112 |
| 2023-06-30 |
$112 |
| 2023-03-31 |
$112 |
| 2022-12-31 |
$116 |
| 2022-09-30 |
$116 |
| 2022-06-30 |
$117 |
| 2022-03-31 |
$119 |
| 2021-12-31 |
$125 |
| 2021-09-30 |
$123 |
| 2021-06-30 |
$125 |
| 2021-03-31 |
$133 |
| 2020-12-31 |
$134 |
| 2020-09-30 |
$135 |
| 2020-06-30 |
$134 |
| 2020-03-31 |
$134 |
| 2019-12-31 |
$134 |
| 2019-09-30 |
$135 |
| 2019-06-30 |
$135 |
| 2019-03-31 |
$134 |
| 2018-12-31 |
$136 |
| 2018-09-30 |
$136 |
| 2018-06-30 |
$136 |
| 2018-03-31 |
$136 |
| 2017-12-31 |
$137 |
| 2017-09-30 |
$137 |
| 2017-06-30 |
$137 |
| 2017-03-31 |
$137 |
| 2016-12-31 |
$140 |
| 2016-09-30 |
$139 |
| 2016-06-30 |
$140 |
| 2016-03-31 |
$143 |
| 2015-12-31 |
$144 |
| 2015-09-30 |
$144 |
| 2015-06-30 |
$144 |
| 2015-03-31 |
$144 |
| 2014-12-31 |
$145 |
| 2014-09-30 |
$145 |
| 2014-06-30 |
$144 |
| 2014-03-31 |
$144 |
| 2013-12-31 |
$152 |
| 2013-09-30 |
$150 |
| 2013-06-30 |
$153 |
| 2013-03-31 |
$158 |
| 2012-12-31 |
$159 |
| 2012-09-30 |
$159 |
| 2012-06-30 |
$158 |
| 2012-03-31 |
$158 |
| 2011-12-31 |
$159 |
| 2011-09-30 |
$158 |
| 2011-06-30 |
$158 |
| 2011-03-31 |
$161 |
| 2010-12-31 |
$176 |
| 2010-09-30 |
$173 |
| 2010-06-30 |
$179 |
| 2010-03-31 |
$180 |
| 2009-12-31 |
$186 |
| 2009-09-30 |
$185 |
| 2009-06-30 |
$185 |
| 2009-03-31 |
$189 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$19.711B |
$9.872B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
